SCHEMBL19775784

SCHEMBL19775784

O=CNC1=CCCc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.39
ALDH1A1 P00352 4/20 0.36
MAOB P27338 2/20 0.36
CYP2A6 P11509 1/20 0.36
MAOA P21397 1/20 0.36
PDPK1 O15530 1/20 0.34
PARP1 P09874 1/20 0.34
PARP10 Q53GL7 1/20 0.34
PARP11 Q9NR21 1/20 0.34
PABPC1 P11940 1/20 0.34
MAPT P10636 5/20 0.33
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
TP53 P04637 2/20 0.33
HTT P42858 2/20 0.33
MPI P34949 2/20 0.33
PKM P14618 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826687 0.83 ALDH1A1 (0.40) CES1ALDH1A1MAOBCYP2A6MAOA
SCHEMBL12843388 0.76 CES1 (0.39) CES1ALDH1A1MAOBCYP2A6MAOA
SCHEMBL31301103 0.72 NPC1 (0.53) CES1ALDH1A1MAOAMAPTNPC1
SCHEMBL1200124 0.72 NPC1 (0.53) CES1ALDH1A1MAOAMAPTNPC1
SCHEMBL29139832 0.72 SMN1; SMN2 (0.42) CES1ALDH1A1MAOBCYP2A6MAOA
SCHEMBL7749803 0.72 CES1 (0.43) CES1MAOBCYP2A6MAOAPDPK1
SCHEMBL29648452 0.72 CES1 (0.43) CES1MAOBCYP2A6MAOAPDPK1
SCHEMBL23181452 0.71 CES1 (0.35) CES1ALDH1A1MAOBCYP2A6MAOA
SCHEMBL2674629 0.71 SIGMAR1 (0.43) CES1ALDH1A1MAOBCYP2A6MAOA
SCHEMBL4771351 0.70 CYP1A2 (0.35) CES1ALDH1A1MAOBCYP2A6MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109438272-A The synthetic method of C5a receptor antagonist W-54011 常州大学 2019-03-08 CN disclosed
US-10011559-B2 Preparation of chiral amides and amines SUNOVION PHARMACEUTICALS INC. (US) 2018-07-03 US disclosed
US-20180016224-A1 PREPARATION OF CHIRAL AMIDES AND AMINES SUNOVION PHARMACEUTICALS INC. 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10011559-B2 Preparation of chiral amides and amines PNMT, ALKBH5, ALKBH2 CES1 1643/4885ALDH1A1 501/4885MAOB 627/4885
US-20180016224-A1 PREPARATION OF CHIRAL AMIDES AND AMINES PNMT, ALKBH2, ALKBH5 CES1 1627/4885ALDH1A1 523/4885MAOB 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.